Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...

Kronos Advanced Technologies Inc. owns all common shares and maintains full voting control of KronosMD Inc. Additionally, KronosMD’s preferred shareholders collectively hold over 5,000,000 shares with ...

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday ...

A rumor regarding Legend Biotech (LEGN) was highlighted in an alert sent to subscribers of Ben Harrington’s takeover-focused Betaville blog, contacts tell The Fly. Shares of Legend Biotech ...

Prime Minister Narendra Modi on Thursday released the genome sequencing data of 10,000 Indian nationals and said it will be a milestone in the field of biotechnology research. The Genome India ...

Biotechnology contributes to this aspect of the plastics industry while providing end-of-life waste management solutions via enzymatic recycling, facilitating monomer recovery under milder conditions ...

In 2024, Fierce Biotech reported 192 industry layoff rounds, which is 3% higher than in 2023, when 187 rounds were tallied. Rounds are reported as they are disclosed and are not combined per ...

Re­gen­eron, mak­er of the block­buster oph­thal­mol­o­gy med­i­cine Eylea, has ac­quired an oc­u­lar biotech, the large bio­phar­ma con­firmed to End­points News on Thurs­day.

No Oxular employees are joining Regeneron, though several will be “helping short-term with tech transfer and transition work in consulting roles,” a Regeneron spokesperson told Fierce Biotech ...

2024 was the year of the pri­vate megaround. Nine-fig­ure fi­nanc­ings dom­i­nat­ed biotech’s ven­ture fund­ing land­scape, with 96 such rounds tal­lied by End­points News. The bevy … ...

Carmell acquires Elevai Skincare, adding $2.5M in annual revenue and advanced exosome technology to its portfolio. Deal includes $1.1M in equity, $57K in cash, and earnouts tied to sales and ...